De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03): 5-year follow-up results of a Dutch, prospective, registry study

Primary chemotherapy in breast cancer poses a dilemma with regard to adjuvant locoregional radiotherapy, as guidelines for locoregional radiotherapy were originally based on pathology results of primary surgery. We aimed to evaluate the oncological safety of de-escalated locoregional radiotherapy in...

Full description

Saved in:

Bibliographic Details
Published in:	The lancet oncology Vol. 23; no. 9; pp. 1201 - 1210
Main Authors:	de Wild, Sabine R, de Munck, Linda, Simons, Janine M, Verloop, Janneke, van Dalen, Thijs, Elkhuizen, Paula H M, Houben, Ruud M A, van Leeuwen, A Elise, Linn, Sabine C, Pijnappel, Ruud M, Poortmans, Philip M P, Strobbe, Luc J A, Wesseling, Jelle, Voogd, Adri C, Boersma, Liesbeth J
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 01.09.2022 Elsevier Limited
Subjects:	Biopsy Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - radiotherapy Cancer therapies Chemotherapy Female Follow-Up Studies Hematology, Oncology, and Palliative Medicine Humans Lymphatic system Mammography Mastectomy Medical diagnosis Medical prognosis Medical research Metastasis Neoplasm Recurrence, Local - pathology Patients Radiation Oncology Radiation therapy Radiotherapy, Adjuvant Registries Review boards Risk groups Surgery Translation Netherlands
ISSN:	1470-2045, 1474-5488, 1474-5488
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!